{"schema_version":"secwatch.filing_event.v1","accession":"0001157523-23-001599","form_type":"8-K","ticker":"CCRN","cik":"0001141103","company_name":"CROSS COUNTRY HEALTHCARE INC","filed_at":"2023-11-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:28.338595+00:00","generated_at":"2026-06-09T02:01:42.378491+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Cross Country Healthcare Q3 revenue $442M (-30% YoY), net income $12.8M (-63%), EPS $0.36 vs loss $0.57","bullets":["Revenue of $442.3M, down 30% from Q3 2022 and 18% from Q2 2023.","Net income $12.8M, down 63% YoY and 40% sequentially.","Diluted EPS of $0.36, compared to a loss of $0.57 in Q3 2022.","Adjusted EBITDA $27.2M (6.2% margin), down 57% YoY and 380 bps margin contraction.","Operating cash flow $70.3M, down 50% from Q3 2022."],"urls":{"canonical":"https://secwatch.observer/filing/0001157523-23-001599","json":"https://secwatch.observer/filing/0001157523-23-001599.json","markdown":"https://secwatch.observer/filing/0001157523-23-001599.md","text":"https://secwatch.observer/filing/0001157523-23-001599.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1141103/000115752323001599/0001157523-23-001599-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1141103/000115752323001599/a53715943.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-09T02:01:42.378491+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"90ee34d26110a3f076280f1c6fd462e5064bfd91","claim":"CROSS COUNTRY HEALTHCARE INC reported financial results for quarter ended September 30, 2023.","evidence_excerpt":"On November 1, 2023 , Cross Country Healthcare, Inc. (“the Company”) issued a press release announcing results for the quarter ended September 30, 2023 , a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1141103/000115752323001599/0001157523-23-001599-index.htm","confidence":0.65,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended September 30, 2023"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}